T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
CTS Corp
CTS
$1.79B
| $36.4M | 0.01% |
1,509,466
-1,160
| -0.1% | -$26K |
|
977
Matthews International
MATW
$722M
| $36.3M | 0.01% |
583,159
-143,481
| -20% | -$8.95M |
|
978
Black Hills Corp
BKH
$5.64B
| $36M | 0.01% |
522,005
+172,140
| +49% | +$12M |
|
979
Jack Henry & Associates
JKHY
$11.1B
| $35.9M | 0.01% |
349,705
+58,921
| +20% | +$6.1M |
|
|
HI
980
DELISTED
Hillenbrand
HI
| $35.8M | 0.01% |
921,206
-11,792
| -1% | -$428K |
|
981
Inogen
INGN
$154M
| $35.7M | 0.01% |
375,044
+35,422
| +10% | +$3.42M |
|
982
MACOM Technology Solutions
MTSI
$23.5B
| $35.7M | 0.01% |
799,160
+110,350
| +16% | +$5.38M |
|
983
Azenta
AZTA
$1.49B
| $35.6M | 0.01% |
1,171,324
-661,950
| -36% | -$17M |
|
|
WFBI
984
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $35.6M | 0.01% |
999,100
-9,490
| -0.9% | -$322K |
|
985
Sarepta Therapeutics
SRPT
$1.95B
| $35.5M | 0.01% |
782,781
+515,862
| +193% | +$20.6M |
|
986
Kaiser Aluminum
KALU
$2.99B
| $35.5M | 0.01% |
343,861
+288,434
| +520% | +$27.8M |
|
987
NCR Voyix
VYX
$1.17B
| $35.4M | 0.01% |
1,538,731
+156,271
| +11% | +$3.59M |
|
988
Perdoceo Education
PRDO
$1.99B
| $35.4M | 0.01% |
3,407,714
-34,700
| -1% | -$322K |
|
|
CHSP
989
DELISTED
Chesapeake Lodging Trust
CHSP
| $35.3M | 0.01% |
1,309,218
-5,470
| -0.4% | -$138K |
|
|
BZUN
990
Baozun
BZUN
$168M
| $35.2M | 0.01% |
1,073,806
-744,489
| -41% | -$23.5M |
|
|
MYOK
991
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $35.1M | 0.01% |
818,125
+676,939
| +479% | +$21.6M |
|
992
Cadence Design Systems
CDNS
$89.2B
| $35M | 0.01% |
887,168
-2,127,176
| -71% | -$78.4M |
|
993
Motorola Solutions
MSI
$77B
| $35M | 0.01% |
412,205
+4,206
| +1% | +$368K |
|
994
Cencora
COR
$59.2B
| $34.8M | 0.01% |
421,113
-526,305
| -56% | -$44.7M |
|
995
Brown-Forman Class B
BF.B
$12.9B
| $34.7M | 0.01% |
999,805
-11,547
| -1% | -$375K |
|
996
Jacobs Solutions
J
$16.8B
| $34.6M | 0.01% |
716,995
-3,951
| -0.5% | -$177K |
|
997
Harmonic Inc
HLIT
$1.42B
| $34.4M | 0.01% |
11,284,453
+169,547
| +2% | +$630K |
|
998
Brunswick
BC
$5.29B
| $34.4M | 0.01% |
614,908
+29,989
| +5% | +$1.68M |
|
999
NewMarket
NEU
$8.72B
| $34.4M | 0.01% |
80,819
+1,942
| +2% | +$848K |
|
|
KAMN
1000
DELISTED
Kaman Corp
KAMN
| $34.4M | 0.01% |
615,836
-7,300
| -1% | -$368K |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.